After Hours
$
4.25
Change
-0.03 -0.70%
Volume
Volume 9,567
Feb 25, 2021, 7:59 p.m.
Quotes are delayed by 20 min
Today's close
$ 4.14
$ 4.28
Change
+0.14 +3.38%
Day low
Day high
$4.16
$4.60

52 week low
52 week high
$1.42
$5.70

Market cap
$447.25M
Average volume
2.29M
P/E ratio
N/A
Rev. per Employee
$171,205
EPS
-0.83
Dividend
N/A
Div yield
N/A
Ex dividend date
N/A
MarketWatch News on SELB
-
Selecta Biosciences upgraded to buy from neutral at Mizuho
- Tomi Kilgore
-
Selecta Biosciences stock price target raised to $8.00 from $2.50 at Mizuho
- Tomi Kilgore
-
Selecta Biosciences downgraded to neutral from buy at Mizuho Securities, price target to $2.50 from $7
- Tonya Garcia
-
Selecta Biosciences started at buy with $23 stock price target at Stifel Nicolaus
- Tomi Kilgore
-
ValueAct Capital Revisits Alliance Data Systems
- Barron's Online
Analyst Ratings
-
Benzinga's Top Upgrades, Downgrades For February 27, 2018
- Benzinga.com
-
- Benzinga.com
Other News on SELB
-
GME, AMC, TNXP and NGA among premarket gainers
- Seeking Alpha
-
TLRY, GWPH, SSL and DGNR among premarket gainers
- Seeking Alpha
-
GME, OSTK, AQMS and PEI among premarket gainers
- Seeking Alpha
-
Selecta: ImmTOR Platform's Potential In Key
- Seeking Alpha
-
Nanobiotix Pursues $96 Million IPO Plan
- Seeking Alpha
-
- Edgar Online - (EDG = 10Q, 10K)
-
Selecta Biosciences News: SELB Stock Shoots 9% Higher on Insider Buying Buzz
- InvestorPlace.com
-
SAP, DNKN, CODX and NNDM among midday movers
- Seeking Alpha
-
DNKN, JMIA among premarket gainers
- Seeking Alpha
-
SNAP, NKLA, PINS and ERIC among premarket gainers
- Seeking Alpha
- Loading more headlines...
Press Releases on SELB
-
Third Pole Therapeutics Expands Board of Directors
- PR Newswire - PRF
- Loading more headlines...
Rates »
National averages from Bankrate.com
National averages from Bankrate.com
National averages from Bankrate.com